Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Early PCI better than conservative treatment for heart attack patients in remote areas

This article was originally published in Clinica

Executive Summary

When heart attacks strike individuals in rural areas, thrombolysis followed by immediate transfer for angiography is a better treatment strategy than thrombolysis followed by conservative, community-hospital follow-up. The 266-patient NORDISTEMI trial, presented at the ESC meeting, studied the effect of early percutaneous coronary intervention (PCI) after fibrinolysis in heart attack patients resident in areas of Norway 100-400km from the nearest PCI centre. It took around 130 minutes to get the patients to these centres. A composite of death, recurrence of heart attack or stroke at 12 months was significantly reduced in the early invasive group compared to the conservative group, the trial showed.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT044255

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel